Cart
sales@molnova.com
Retigabine
CAS No. 150812-12-7
Retigabine( D 23129 | GKE-841 | GW 582892X | WAY-143841 )
Catalog No. M12105 CAS No. 150812-12-7
Retigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRetigabine
-
NoteResearch use only, not for human use.
-
Brief DescriptionRetigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
-
DescriptionRetigabine (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity.
-
In Vitro——
-
In Vivo——
-
SynonymsD 23129 | GKE-841 | GW 582892X | WAY-143841
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorKCNQ2/Q3 channels| KCNQ3/5| KCQN4
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number150812-12-7
-
Formula Weight303.33
-
Molecular FormulaC16H18FN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.M.J. Brodie, et al. Neurology November 16, 2010 vol. 75 no. 20 1817-1824 .
molnova catalog
related products
-
Tolazamide
Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.
-
ML418
ML418 is a potent, selective and CNS penetrating Kir7.1 potassium channel blocker (IC50 = 310 nM), and also potently inhibits Kir6.2/SUR1.
-
PF-04895162
PF-04895162 (ICA-105665, PF 4895162) is an orally available agonist of neuronal Kv7 potassium channel, opens Kv7.2/7.3 and Kv7.3/7.5 potassium channels.
